Ophthalmology · Princeton, NJ
NPI
1376851709
Since 2010
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
419 N Harrison St
Princeton, NJ, 08540
Phone (609) 921-9437
Groups this clinician bills Medicare through
Medicare paid, 2024
$455K
6,105 services
Medicare patients, 2024
1,376
Average age 78
Drug cost, 2024
$1.1M
6,217 prescriptions
Company payments, 2025
$841
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah D Kuchar was code 92012 (ophthalmological e&m), 1,408 times for 778 patients. In total Sarah D Kuchar billed 6,105 services in 43 codes, and Medicare paid $455K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 1,408 | 778 | $68.46 | $96K |
| 92014 Ophthalmological E&M | Office | 740 | 711 | $95.45 | $71K |
| 92133 Computerized Ophthalmic Imaging | Office | 621 | 604 | $28.07 | $17K |
| 92083 Vision, Hearing, and Speech Services | Office | 521 | 482 | $50.08 | $26K |
| 92250 Angiography | Office | 352 | 342 | $28.18 | $9,919 |
| 92136 Ultrasound - Nonspecific | Office | 274 | 111 | $20.84 | $5,711 |
| 99214 Office E&M - Established | Office | 232 | 226 | $95.19 | $22K |
| 68841 Eye | Facility | 196 | 141 | $13.88 | $2,720 |
| 66984 Cataract Surgery | Facility | 135 | 87 | $430.13 | $58K |
| 92020 Ophthalmological E&M | Office | 117 | 116 | $21.43 | $2,507 |
| 76514 Ultrasound - Nonspecific | Office | 77 | 77 | $8.93 | $688 |
| 92004 Ophthalmological E&M | Office | 72 | 72 | $100.51 | $7,236 |
| 92134 Computerized Ophthalmic Imaging | Office | 72 | 71 | $32.51 | $2,341 |
| 66821 Cataract Surgery | Facility | 66 | 54 | $261.61 | $17K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Facility | 61 | 45 | $165.85 | $10K |
By year: 2022 $497K for 5,499 services; 2023 $503K for 5,694 services; 2024 $455K for 6,105 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah D Kuchar prescribed most often to Medicare patients was Latanoprost, with 1,376 prescriptions and refills. In total Sarah D Kuchar wrote 6,217 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,376 | 3,664 | 453 | $21K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 995 | 2,648 | 328 | $26K |
| Timolol Maleate Generic | 713 | 1,862 | 238 | $16K |
| Lumigan Bimatoprost | 404 | 961 | 117 | $241K |
| Brimonidine Tartrate Generic | 389 | 959 | 124 | $49K |
| Prednisolone Acetate Generic | 221 | 396 | 126 | $16K |
| Dorzolamide Hcl Generic | 210 | 526 | 71 | $6,314 |
| Alphagan P Brimonidine Tartrate | 170 | 349 | 52 | $79K |
| Combigan Brimonidine Tartrate/Timolol | 156 | 357 | 47 | $79K |
| Rhopressa Netarsudil Mesylate | 148 | 326 | 50 | $97K |
| Travoprost Generic | 140 | 301 | 42 | $28K |
| Simbrinza Brinzolamide/Brimonidine Tart | 139 | 272 | 36 | $45K |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 128 | 163 | 118 | $980 |
| Erythromycin Erythromycin Base | 119 | 135 | 53 | $1,747 |
| Vyzulta Latanoprostene Bunod | 100 | 204 | 29 | $60K |
Brand drugs: 2,040 claims; generic drugs: 4,177 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah D Kuchar $841 ($841 in general payments such as food, travel and fees) from 12 companies. The largest payer was Alcon Vision LLC with $345.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 8 | $345 |
| Astellas Pharma US Inc 4503.T | 1 | $132 |
| Dompe US, Inc. | 1 | $119 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $56.88 |
| Sight Sciences, Inc. SGHT | 1 | $49.43 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $38.62 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $19.49 |
| Harrow Eye, LLC | 1 | $17.76 |
| Amgen Inc. AMGN | 1 | $17.3 |
| Glaukos Corporation GKOS | 1 | $16.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.